Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030

icon1
USD 1.80 BN
MARKET SIZE, 2030
icon2
CAGR 4.0%
(2025-2030)
icon3
244
REPORT PAGES
icon4
200
MARKET TABLES

OVERVIEW

Mainframe Modernization Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0%. The rising incidence of dental issues, such as periodontal diseases and dental caries worldwide, is one of the main factors propelling the market expansion for dental anesthetics. The market for dental anesthetics is estimated to grow substantially over the course of the forecast period due to the rise in dental tourism.

KEY TAKEAWAYS

  • BY DRUG TYPE
    Lidocaine accounted for the largest share of the dental anesthetics market by drug type due to its well-established clinical efficacy, rapid onset of action, and favorable safety profile. It is widely used as both an injectable and a topical anesthetic across a broad range of dental procedures.
  • BY ROUTE OF ADMINISTRATION
    The dental anesthetics market is segmented by route of administration into topical anesthetics, injectable anesthetics, and syringes & needles. Injectable anesthetics dominate due to their fast onset, reliability, and deep, long-lasting numbness, which are suitable for complex procedures. Their versatility across routine and surgical applications, along with customizable dosage and duration, contributes to their larger market share.
  • BY END USER
    The demand for dental anesthetics is largely influenced by dental clinics. This is due to the increasing modernization of dental clinics and rising interest in cosmetic and restorative dental procedures.
  • BY REGION
    The dental anesthetics market covers Europe, North America, Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries. Asia Pacific is projected to grow the fastest, at a CAGR of 4.8%, primarily driven by rising oral health awareness, expanding middle-class populations, and an increasing burden of dental caries and periodontal diseases.
  • COMPETITIVE LANDSCAPE
    The major market players have adopted both organic and inorganic strategies, including partnerships and collaborations. In December 2024, Septodont Holding (France) announced a strategic investment in Balanced Pharma, Inc. (US), a company developing next-generation dental anesthetics that retain standard cartridge format, safety, efficacy, and shelf life.

A blend of demographic, medical, and environmental factors is responsible for propelling the growth of the dental anesthetics market. One example is the increase in global dental conditions. Dental caries, periodontitis, and tooth extractions are some of the dental ailments typically seen due to unhealthy dietary habits, an aging population, and the constantly rising consumption of sugar-based products.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The dental anesthetics market is undergoing a significant transformation, driven by advancements in anesthesia delivery technologies, evolving dental care models, rising dental disease prevalence, and changing patient expectations. While traditional revenue sources such as topical anesthetics, injectable anesthetics, syringes, and needles remain central, emerging trends like computer-controlled local anesthetic delivery systems, needle-free jet injectors, iontophoresis, pulsewave technology, intraosseous anesthesia systems, and vibration analgesia devices are reshaping the market landscape. These disruptions are creating new high-growth opportunities and applications for manufacturers, while also influencing the end-user profile across hospitals & dental clinics, dental support organizations, and other facilities.

Mainframe Modernization Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increase in patient pool for dental treatments
  • Rise in demand for advanced cosmetic dental procedures
RESTRAINTS
Impact
Level
  • Potential adverse effects
OPPORTUNITIES
Impact
Level
  • Rise in number of DSOs and growing private equity investments
  • Growing dental tourism
CHALLENGES
Impact
Level
  • Dearth of trained dental practitioners
  • Needle phobia

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increase in patient pool for dental treatments

The growing number of people undergoing dental procedures, which is being driven by the incidence of oral diseases, aging populations, and greater tooth loss, is one of the primary reasons driving the dental anesthetics market. Of the 3.5 billion persons with oral health problems, the WHO estimates that 2.4 billion have cavities that have not been addressed. Smoking, eating too much sugar, not practicing good oral hygiene, and drinking alcohol are some of the factors that contribute to the decline of dental health. Lack of access to preventive care exacerbates the issue, particularly in disadvantaged communities. Growing patient awareness, improved healthcare infrastructure, expansion of dental clinics, and technical advancements in needle-free anesthetics delivery have made dental procedures requiring local anesthetics more popular.

Restraint: Potential side effects

The potential for side effects is a major obstacle to the dental anesthetics market's growth. Patients and medical professionals are worried about possible side effects such as allergic responses, systemic toxicity, and nerve damage, even though local anesthesia is normally safe. The negative effects include anomalies of the eyes, neurological impairment (such as persistent paresthesia), and rare cardiovascular problems (such as isolated atrial fibrillation). Ocular abnormalities, neurological impairment (like chronic paresthesia), and uncommon cardiovascular issues (like isolated atrial fibrillation) are also among the side effects. Nerve injuries are uncommon, but they can result in long-lasting sensory impairments that undermine a patient's confidence. Allergic responses to medications such as lidocaine and articaine have been documented; these reactions can sometimes have severe repercussions. Additionally, procedural issues such as incorrect technique, overdosage, and needle breakage enhance the likelihood of complications. Collectively, these safety issues prevent broader market adoption by discouraging patients from accepting dental procedures, exposing products to more stringent regulatory scrutiny.

Opportunity: Increase in demand across emerging countries

Large patient populations, rising middle-class incomes, and rising knowledge of dental treatment in emerging economies like China, India, and Mexico are expected to increase demand for dental anesthetics significantly. Dental tourism is flourishing in Brazil and Mexico due to their reasonably priced dental care. The rising geriatric population in these countries also offers a major opportunity for growth in dental anesthetics. China's old population is predicted to reach 402 million by 2040, while India's is predicted to grow from 153 million in 2024 to 347 million by 2050. So, Global population ageing is a sign of a broader trend that makes dental care more important in emerging countries.

Challenge: Dearth of trained dental practitioners

According to the National Health Resources and Services Administration (HRSA), almost 59 million people are affected by the 6,888 designated dental health professional shortage areas (HPSAs) as of 2024. Also, an extra 10,093 dentists would be required in the US to address these shortages. A similar problem of dental health professionals in short supply is found in many parts of the world, including Africa, Asia, and Latin America. According to a 2023 World Health Organisation (WHO) study, Africa had just 3.3 dentists per 100,000 people between 2014 and 2019, which is roughly a tenth of the global average. Despite the high patient volume in these areas, the lack of dentists presents a serious obstacle to the uptake of dental equipment, including dental anesthetics.

dental anesthetics market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Septoject dental needles designed for atraumatic and precise anesthetic delivery in routine dental procedures Minimize tissue trauma, improve injection comfort, reduce risk of needle breakage, enhance accuracy of anesthetic delivery, widely used across clinics globally
Oraqix (lidocaine/prilocaine topical anesthetic gel) indicated for anesthesia in periodontal scaling and root planing Needle-free anesthesia option, improves patient comfort, rapid onset of action, reduces fear of injections, enhances compliance in minimally invasive periodontal care
Orabloc injectable articaine-based anesthetic used in routine and complex dental procedures Provides strong and reliable anesthesia, rapid onset with extended duration, a favorable safety profile, widely accepted alternative to lidocaine in dental surgeries
Injectable dental anesthetics (lidocaine, articaine formulations) for local anesthesia during various dental treatments Cost-effective solutions ensure consistent efficacy, expanding global availability, a strong presence in emerging Asian markets, supports a broad range of procedures
Ultracaine (articaine hydrochloride with epinephrine) injectable anesthetic for routine and surgical dentistry High potency and fast onset, excellent diffusion in bone tissues, extended duration of action, suitable for complex extractions and surgical interventions

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The ecosystem of the dental anesthetics market includes manufacturers, distributors, research & product developers, and end users. Manufacturers include organizations involved in research, design, product development, optimization, and launch. Distributors include third parties and e-commerce sites linked to the organization for the marketing of dental products. Researchers & product developers include in-house research facilities, contract research organizations, and contract development & manufacturing organizations, which play an essential role in outsourcing research for product development. End users include dentists who use dental anesthetics. On the other hand, investors/funders and health regulatory bodies are the primary influencers in this market.

Mainframe Modernization Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Mainframe Modernization Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Dental Anesthetics Market, by Drug Type

Since articaine has several advantages over other drug types, it is projected to grow at the highest CAGR. Due to its thiophene ring, articaine enhances the lipid solubility and tissue penetration of dental anesthetics. Its ability to diffuse more effectively into both soft and hard tissues makes it especially useful for mandibular infiltrations, where other anesthetics are typically required for nerve blocks. As a result, dentists found the use of articaine better in regions with high bone density. Several studies have also demonstrated its safety profile when administered as prescribed, especially in patient demographics that include both geriatric and pediatric patients.

Dental Anesthetics Market, by Route of Administration

The market for dental anesthetics is divided into four segments based on the route of administration: topical anesthetics, injectable anesthetics, syringes, and needles. Among them, injectable anesthetics are set to record the largest share due to factors like fast onset, high reliability, precise targeting through nerve blocks, and improvements in injection techniques. They provide deep and longer-lasting numbness, which makes them increasingly useful for more complex dental procedures. Because of their versatility in a range of procedures, from simple fillings and deep cleanings to complex. surgeries, root canals, and implant placements, dentists and oral surgeons are using them more frequently. Additionally, because injectable anesthetics can be tailored for dosage, technique, and duration, they are very popular and hold a larger market share in the dental anesthetics industry.

Dental Anesthetics Market, by End User

For various reasons, dental clinics hold the largest market share for dental anesthetics among all end users. More dental clinics are adopting the use of advanced anesthetic systems to precisely handle difficult dental cases, including those requiring specialized solutions. Their ability to treat a large number of patients and their wide availability are further enhanced by the presence of qualified professionals who can deliver top-notch dental care. Also, due to their well-established reputation, patients prefer to receive their dental care at dental clinics. Their competitive advantage in the dental anesthetics market is further strengthened by their capacity to provide a range of services under one roof, including general dentistry and endodontic procedures.

REGION

Asia Pacific to be fastest-growing region in global dental anesthetics market during forecast period

Due to a number of variables, the dental anesthetics market in Asia Pacific is projected to grow at the highest rate. The need for tooth loss treatments is driven by an aging population, while governments are promoting oral health awareness and providing subsidies. Dental care is part of the burgeoning middle class, and rising incomes are driving up healthcare costs. Dental products like implants, dentures, and veneers are still incredibly underused in many Asian nations, which offers significant growth potential for dental anesthetics. Demand is also being increased by the rise in medical tourism to nations like South Korea, Thailand, and India, which provide affordable, high-quality dental care. Asia Pacific is positioned as a major growing market for dental anesthetics due to the region's changing healthcare landscape, as well as greater accessibility and awareness.

Mainframe Modernization Market Region

dental anesthetics market: COMPANY EVALUATION MATRIX

In the dental anesthetics market matrix, Septodont Holding (Star) leads with a dominant market share and a comprehensive product footprint, driven by its broad portfolio of local anesthetics, advanced formulations, and strong global distribution network. The company’s continuous innovation in safer, more effective anesthetic solutions and its established brand reputation among dental professionals reinforce its leadership position. DFL Indústria e Comércio S/A (Emerging Leader) is gaining traction with its expanding range of dental anesthetic products and growing presence in Latin America. Through focused innovation, competitive pricing, and increasing exports, DFL is steadily strengthening its global visibility. While Septodont maintains leadership through scale, trust, and diversified offerings, DFL demonstrates strong potential to advance toward the leaders’ quadrant as demand for cost-effective, high-quality dental anesthetics continues to accelerate in emerging markets.

Mainframe Modernization Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size, 2024 (Value) USD 1.43 Billion
Market Forecast, 2030 (Value) USD 1.80 Billion
Growth Rate CAGR of 4.0% from 2025 to 2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion), Volume (Thousand Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Drug Type:
    • Lidocaine
    • Mepivacaine
    • Articaine
    • Bupivacaine
    • Prilocaine
    • Others
  • By Route of Administration:
    • Topical Anesthetics
    • Injectable Anesthetics
    • Syringes
    • Needles
  • By End User:
    • Hospitals
    • Dental Clinics
    • Others
Regions Covered Europe, North America, Asia Pacific, Latin America, Middle East & Africa, GCC Countries

WHAT IS IN IT FOR YOU: dental anesthetics market REPORT CONTENT GUIDE

Mainframe Modernization Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis
  • Assessed the local dental anesthetics market
  • Calculated the market size for total syringes and needles used in dental anesthetics market
Identify interconnections and potential supply chain blind spots within the dental ecosystem
Company Information
  • Key players: Septodont Holding (France), Dentsply Sirona (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), and DFL Indústria e Comércio S/A (Brazil)
  • Market share analysis of Top 3–5 Players in countries of APAC and Europe
Insights on revenue shifts toward emerging innovations
Geographic Analysis Detailed analysis on Rest of Asia Pacific was provided to one of the top players Country-level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • May 2024 : Laboratorios Inibsa (Spain), part of Septodont (France), announced the launch of Prestoject dental syringes. These syringes were designed to be compatible with 1.8?mL dental cartridges and needles with metric threads.
  • December 2024 : Septodont Holding (France) announced a strategic investment in Balanced Pharma, Inc. (US), a company developing next-generation dental anesthetics that retain standard cartridge format, safety, efficacy, and shelf life.
  • October 2024 : Septodont Holding (France) acquired a 51% controlling stake in Laboratorios Inibsa (Spain), a Spain-based pharmaceutical group specializing in injectable anesthetics and dental products, with Acteon (France) joining as a non-controlling partner.
  • August 2023 : Pierrel (Italy) acquired 3M's (US) Dental Local Anesthetic portfolio, including brands such as Ubistesin, Xylestesin, and Mepivastesin.
  • April 2022 : Pierrel (Italy) launched the Orabloc Dental Needles in the US. They would be available in five types, each associated with specific anesthesia needs in the dental field.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
23
2
RESEARCH METHODOLOGY
 
 
 
27
3
EXECUTIVE SUMMARY
 
 
 
43
4
PREMIUM INSIGHTS
 
 
 
46
5
MARKET OVERVIEW
Expanding dental market driven by advanced procedures, rising DSOs, and emerging global opportunities.
 
 
 
50
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
INCREASING PATIENT POOL FOR DENTAL TREATMENTS
 
 
 
 
5.2.1.2
INCREASING DEMAND FOR ADVANCED COSMETIC DENTAL PROCEDURES
 
 
 
 
5.2.1.3
TECHNOLOGICAL ADVANCEMENTS IN ANESTHETIC DELIVERY
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
POTENTIAL ADVERSE EFFECTS
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
RISING NUMBER OF DSOS AND GROWING PRIVATE EQUITY INVESTMENTS
 
 
 
 
5.2.3.2
EMERGING MARKETS
 
 
 
 
5.2.3.3
GROWING DENTAL TOURISM
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
DEARTH OF TRAINED DENTAL PRACTITIONERS
 
 
 
 
5.2.4.2
NEEDLE PHOBIA
 
 
5.3
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.3.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
5.3.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.3.3
BARGAINING POWER OF BUYERS
 
 
 
 
5.3.4
THREAT OF SUBSTITUTES
 
 
 
 
5.3.5
THREAT OF NEW ENTRANTS
 
 
 
5.4
REGULATORY ANALYSIS
 
 
 
 
 
5.4.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
5.4.2
REGULATORY LANDSCAPE
 
 
 
5.5
INDUSTRY TRENDS
 
 
 
 
 
5.5.1
METERED SPRAY SYSTEMS
 
 
 
 
5.5.2
JET INJECTION SYSTEMS
 
 
 
5.6
REIMBURSEMENT SCENARIO
 
 
 
 
5.7
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.7.1
KEY TECHNOLOGIES
 
 
 
 
 
5.7.1.1
VASOCONSTRICTORS
 
 
 
 
5.7.1.2
BUFFERING AGENTS
 
 
 
5.7.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.7.2.1
COMPUTER-CONTROLLED LOCAL ANESTHETIC DELIVERY (CCLAD) SYSTEMS
 
 
 
5.7.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.7.3.1
REVERSAL AGENTS
 
 
5.8
KEY CONFERENCES & EVENTS, 2025–2026
 
 
 
 
5.9
PRICING ANALYSIS
 
 
 
 
 
 
5.9.1
AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION
 
 
 
 
5.9.2
INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER
 
 
 
5.10
TRADE ANALYSIS
 
 
 
 
 
 
5.10.1
IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024
 
 
 
 
5.10.2
EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020–2024
 
 
 
5.11
PATENT ANALYSIS
 
 
 
 
 
 
5.11.1
PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS
 
 
 
 
5.11.2
JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET
 
 
 
5.12
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.13
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.14
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
5.15
CASE STUDY ANALYSIS
 
 
 
 
 
5.15.1
CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY
 
 
 
 
5.15.2
CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA
 
 
 
 
5.15.3
CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES
 
 
 
5.16
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
5.17
KEY STAKEHOLDERS & BUYING CRITERIA
 
 
 
 
 
 
5.17.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.17.2
BUYING CRITERIA
 
 
 
5.18
ADJACENT MARKET ANALYSIS
 
 
 
 
5.19
UNMET NEEDS/END-USER EXPECTATIONS
 
 
 
 
5.20
IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET
 
 
 
 
 
5.21
IMPACT OF 2025 US TARIFF – OVERVIEW
 
 
 
 
 
 
5.21.1
INTRODUCTION
 
 
 
 
5.21.2
KEY TARIFF RATES
 
 
 
 
5.21.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.21.4
IMPACT ON END-USER INDUSTRIES
 
 
6
DENTAL ANESTHETICS MARKET, BY DRUG TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 8 Data Tables
 
 
 
89
 
6.1
INTRODUCTION
 
 
 
 
6.2
LIDOCAINE
 
 
 
 
 
6.2.1
RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET
 
 
 
6.3
MEPIVACAINE
 
 
 
 
 
6.3.1
UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET
 
 
 
6.4
ARTICAINE
 
 
 
 
 
6.4.1
IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET
 
 
 
6.5
BUPIVACAINE
 
 
 
 
 
6.5.1
PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH
 
 
 
6.6
PRILOCAINE
 
 
 
 
 
6.6.1
LOWER TOXICITY PROFILE TO FUEL UPTAKE
 
 
 
6.7
OTHER DRUG TYPES
 
 
 
7
DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million and Units | 7 Data Tables
 
 
 
103
 
7.1
INTRODUCTION
 
 
 
 
7.2
TOPICAL ANESTHETICS
 
 
 
 
 
7.2.1
GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND
 
 
 
7.3
INJECTABLE ANESTHETICS
 
 
 
 
 
7.3.1
HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET
 
 
 
7.4
SYRINGES
 
 
 
 
 
7.4.1
ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET
 
 
 
7.5
NEEDLES
 
 
 
 
 
7.5.1
RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH
 
 
8
DENTAL ANESTHETICS MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
 
 
 
114
 
8.1
INTRODUCTION
 
 
 
 
8.2
HOSPITALS
 
 
 
 
 
8.2.1
ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET
 
 
 
8.3
DENTAL CLINICS
 
 
 
 
 
8.3.1
RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET
 
 
 
8.4
OTHER END USERS
 
 
 
9
DENTAL ANESTHETICS MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 15 Countries | 94 Data Tables.
 
 
 
121
 
9.1
INTRODUCTION
 
 
 
 
9.2
EUROPE
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
9.2.2
GERMANY
 
 
 
 
 
9.2.2.1
FAVORABLE GOVERNMENT POLICIES FOR REIMBURSEMENT TO EXPEDITE GROWTH
 
 
 
9.2.3
ITALY
 
 
 
 
 
9.2.3.1
RISING ADOPTION OF DIGITAL DENTISTRY TECHNIQUES TO AUGMENT GROWTH
 
 
 
9.2.4
SPAIN
 
 
 
 
 
9.2.4.1
PRESENCE OF WELL-ESTABLISHED DENTAL HEALTHCARE INFRASTRUCTURE TO FOSTER GROWTH
 
 
 
9.2.5
FRANCE
 
 
 
 
 
9.2.5.1
FAVORABLE DISTRIBUTION NETWORK AND REIMBURSEMENT SCENARIO TO AID GROWTH
 
 
 
9.2.6
UK
 
 
 
 
 
9.2.6.1
BOOMING GERIATRIC POPULATION TO STIMULATE GROWTH
 
 
 
9.2.7
REST OF EUROPE
 
 
 
9.3
NORTH AMERICA
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
9.3.2
US
 
 
 
 
 
9.3.2.1
HIGH PER CAPITA INCOME AND QUALITY OF TREATMENT TO SUPPORT GROWTH
 
 
 
9.3.3
CANADA
 
 
 
 
 
9.3.3.1
RISING HEALTHCARE EXPENDITURE TO SUSTAIN GROWTH
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
9.4.2
SOUTH KOREA
 
 
 
 
 
9.4.2.1
GROWING ELDERLY POPULATION TO FUEL MARKET
 
 
 
9.4.3
JAPAN
 
 
 
 
 
9.4.3.1
SURGE IN AGE-RELATED DENTAL ISSUES TO PROMOTE GROWTH
 
 
 
9.4.4
CHINA
 
 
 
 
 
9.4.4.1
SHIFT IN DEMOGRAPHIC TREND TO ACCELERATE GROWTH
 
 
 
9.4.5
INDIA
 
 
 
 
 
9.4.5.1
GROWING COSMETIC DENTISTRY SECTOR TO FUEL MARKET
 
 
 
9.4.6
AUSTRALIA
 
 
 
 
 
9.4.6.1
INCREASING ACCESS TO DENTAL SERVICES TO FAVOR GROWTH
 
 
 
9.4.7
REST OF ASIA PACIFIC
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
9.5.2.1
BOOMING DENTAL TOURISM TO CONTRIBUTE TO GROWTH
 
 
 
9.5.3
ARGENTINA
 
 
 
 
 
9.5.3.1
GROWING FOCUS ON ORAL HEALTH TO PROPEL MARKET
 
 
 
9.5.4
MEXICO
 
 
 
 
 
9.5.4.1
AFFORDABLE DENTAL CARE COSTS TO AMPLIFY GROWTH
 
 
 
9.5.5
REST OF LATIN AMERICA
 
 
 
9.6
MIDDLE EAST & AFRICA
 
 
 
 
 
9.6.1
GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET
 
 
 
 
9.6.2
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
9.7
GCC COUNTRIES
 
 
 
 
 
9.7.1
INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET
 
 
 
 
9.7.2
MACROECONOMIC OUTLOOK FOR GCC COUNTRIES
 
 
10
COMPETITIVE LANDSCAPE
Discover how top players and emerging startups shape the dental anesthetics market dynamics.
 
 
 
176
 
10.1
INTRODUCTION
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET
 
 
 
10.3
MARKET SHARE ANALYSIS
 
 
 
 
 
10.4
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
10.4.1
STARS
 
 
 
 
10.4.2
EMERGING LEADERS
 
 
 
 
10.4.3
PERVASIVE PLAYERS
 
 
 
 
10.4.4
PARTICIPANTS
 
 
 
 
10.4.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
 
 
 
 
 
10.4.5.1
COMPANY FOOTPRINT
 
 
 
 
10.4.5.2
REGION FOOTPRINT
 
 
 
 
10.4.5.3
DRUG TYPE FOOTPRINT
 
 
 
 
10.4.5.4
ROUTE OF ADMINISTRATION FOOTPRINT
 
 
10.5
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
10.5.1
PROGRESSIVE COMPANIES
 
 
 
 
10.5.2
RESPONSIVE COMPANIES
 
 
 
 
10.5.3
DYNAMIC COMPANIES
 
 
 
 
10.5.4
STARTING BLOCKS
 
 
 
 
10.5.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
10.5.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
10.5.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
10.6
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
10.6.1
FINANCIAL METRICS
 
 
 
 
10.6.2
COMPANY VALUATION
 
 
 
10.7
BRAND/PRODUCT COMPARISON
 
 
 
 
 
10.8
COMPETITIVE SCENARIO
 
 
 
 
 
10.8.1
PRODUCT LAUNCHES
 
 
 
 
10.8.2
DEALS
 
 
 
 
10.8.3
EXPANSIONS
 
 
 
 
10.8.4
OTHER DEVELOPMENTS
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
193
 
11.1
KEY PLAYERS
 
 
 
 
 
11.1.1
SEPTODONT HOLDING
 
 
 
 
 
11.1.1.1
BUSINESS OVERVIEW
 
 
 
 
11.1.1.2
PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
11.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
11.1.1.4
MNM VIEW
 
 
 
11.1.2
DENTSPLY SIRONA
 
 
 
 
11.1.3
PIERREL
 
 
 
 
11.1.4
HUONS GLOBAL
 
 
 
 
11.1.5
NORMON
 
 
 
 
11.1.6
DFL INDÚSTRIA E COMÉRCIO S/A
 
 
 
 
11.1.7
ULTRADENT PRODUCTS INC.
 
 
 
 
11.1.8
PRIMEX PHARMACEUTICALS
 
 
 
 
11.1.9
KEYSTONE INDUSTRIES
 
 
 
 
11.1.10
CLARBEN LABORATORIES
 
 
 
 
11.1.11
HIKMA PHARMACEUTICALS PLC
 
 
 
 
11.1.12
ZEYCO
 
 
 
 
11.1.13
NEW STETIC S.A.
 
 
 
 
11.1.14
CETYLITE, INC.
 
 
 
 
11.1.15
ICPA HEALTH PRODUCTS LIMITED
 
 
 
11.2
OTHER PLAYERS
 
 
 
 
 
11.2.1
CENTRIX, INC.
 
 
 
 
11.2.2
ZYMETH PHARMACEUTICAL
 
 
 
 
11.2.3
DMG AMERICA LLC
 
 
 
 
11.2.4
GC SHOWAYAKUHIN CORPORATION
 
 
 
 
11.2.5
YOUNG INNOVATIONS, INC.
 
 
 
 
11.2.6
CROSSTEX INTERNATIONAL, INC.
 
 
 
 
11.2.7
MARK3 (CARGUS INTERNATIONAL, INC.)
 
 
 
 
11.2.8
J. MORITA CORP.
 
 
 
 
11.2.9
KULZER GMBH
 
 
 
 
11.2.10
INTEGRA LIFESCIENCES CORPORATION
 
 
12
APPENDIX
 
 
 
237
 
12.1
DISCUSSION GUIDE
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
STANDARD CURRENCY CONVERSION RATES
 
 
 
 
TABLE 2
DENTAL ANESTHETICS MARKET: RISK ASSESSMENT ANALYSIS
 
 
 
 
TABLE 3
PROJECTED INCREASE IN NUMBER OF PEOPLE AGED OVER 65 YEARS, BY REGION, 2019 VS. 2050 (MILLION)
 
 
 
 
TABLE 4
US: AVERAGE SPENDING BY PATIENTS ON COSMETIC DENTISTRY SERVICES, 2021 VS. 2022
 
 
 
 
TABLE 5
US: RECENT DEALS BACKED BY PRIVATE EQUITY, 2020–2024
 
 
 
 
TABLE 6
AVERAGE PROCEDURAL COST IN TOP TEN DENTAL TOURISM DESTINATIONS (USD)
 
 
 
 
TABLE 7
DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 8
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 9
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 10
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 11
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 12
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 13
DENTAL ANESTHETICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025–2026
 
 
 
 
TABLE 14
AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION, 2023–2025 (USD)
 
 
 
 
TABLE 15
INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER, 2024
 
 
 
 
TABLE 16
IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020–2024 (USD THOUSAND)
 
 
 
 
TABLE 17
EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), BY COUNTRY, 2020–2024 (USD THOUSAND)
 
 
 
 
TABLE 18
LIST OF PATENTS IN DENTAL ANESTHETICS MARKET (2022−2024)
 
 
 
 
TABLE 19
DENTAL ANESTHETICS MARKET: ROLE IN ECOSYSTEM
 
 
 
 
TABLE 20
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
 
 
 
 
TABLE 21
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
TABLE 22
DENTAL ANESTHETICS MARKET: UNMET NEEDS
 
 
 
 
TABLE 23
DENTAL ANESTHETICS MARKET: END-USER EXPECTATIONS
 
 
 
 
TABLE 24
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 25
KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR DENTAL PRODUCTS
 
 
 
 
TABLE 26
DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 27
DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
DENTAL ANESTHETICS MARKET FOR LIDOCAINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
DENTAL ANESTHETICS MARKET FOR MEPIVACAINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
DENTAL ANESTHETICS MARKET FOR ARTICAINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
DENTAL ANESTHETICS MARKET FOR BUPIVACAINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
DENTAL ANESTHETICS MARKET FOR PRILOCAINE, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
DENTAL ANESTHETICS MARKET FOR OTHER DRUG TYPES, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
DENTAL ANESTHETICS MARKET FOR ROUTE OF ADMINISTRATION, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
TOPICAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
INJECTABLE ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
INJECTABLE ANESTHETICS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
 
 
 
 
TABLE 39
SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
NEEDLES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
DENTAL ANESTHETICS MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
DENTAL ANESTHETICS MARKET FOR DENTAL CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
DENTAL ANESTHETICS MARKET FOR OTHER END USERS, BY COUNTRY 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
DENTAL ANESTHETICS MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
EUROPE: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
GERMANY: DENTIST POPULATION, 2019–2022
 
 
 
 
TABLE 51
GERMANY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 52
GERMANY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
GERMANY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
GERMANY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
ITALY: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 56
ITALY: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
ITALY: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
ITALY: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
SPAIN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 60
SPAIN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
SPAIN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
SPAIN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
FRANCE: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 64
FRANCE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
FRANCE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
FRANCE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
UK: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 68
UK: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
UK: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
UK: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 71
REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 72
REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
REST OF EUROPE: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
US: DENTAL EXPENDITURE, 2014–2023 (USD BILLION)
 
 
 
 
TABLE 75
NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
NORTH AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
US: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
US: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 81
US: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 82
CANADA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 83
CANADA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 84
CANADA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 85
CANADA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 87
ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 88
ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 89
ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 90
SOUTH KOREA: FOREIGN PATIENTS VISITING DENTAL FACILITIES, 2017–2021
 
 
 
 
TABLE 91
SOUTH KOREA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 92
SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 93
SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 94
SOUTH KOREA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
JAPAN: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 96
JAPAN: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 97
JAPAN: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 98
JAPAN: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 99
CHINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 100
CHINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
CHINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
CHINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
INDIA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 104
INDIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
INDIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
INDIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
AUSTRALIA: MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 108
AUSTRALIA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
AUSTRALIA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
AUSTRALIA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
REST OF ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
BRAZIL: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 119
BRAZIL: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
BRAZIL: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
BRAZIL: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
ARGENTINA: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 123
ARGENTINA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
ARGENTINA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
ARGENTINA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
MEXICO: KEY MACROECONOMIC INDICATORS FOR DENTAL ANESTHETICS MARKET
 
 
 
 
TABLE 127
MEXICO: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
MEXICO: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
MEXICO: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
REST OF LATIN AMERICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
MIDDLE EAST & AFRICA: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2023– 2030 (USD MILLION)
 
 
 
 
TABLE 137
GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
GCC COUNTRIES: DENTAL ANESTHETICS MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
STRATEGIES ADOPTED BY KEY PLAYERS IN DENTAL ANESTHETICS MARKET, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 140
DENTAL ANESTHETICS MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 141
DENTAL ANESTHETICS MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 142
DENTAL ANESTHETICS MARKET: DRUG TYPE FOOTPRINT
 
 
 
 
TABLE 143
DENTAL ANESTHETICS MARKET: ROUTE OF ADMINISTRATION FOOTPRINT
 
 
 
 
TABLE 144
DENTAL ANESTHETICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
TABLE 145
DENTAL ANESTHETICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 146
DENTAL ANESTHETICS MARKET: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 147
DENTAL ANESTHETICS MARKET: DEALS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 148
DENTAL ANESTHETICS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 149
DENTAL ANESTHETICS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 150
SEPTODONT HOLDING: COMPANY OVERVIEW
 
 
 
 
TABLE 151
SEPTODONT HOLDING: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 152
SEPTODONT HOLDING: PRODUCTS LAUNCHES, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 153
SEPTODONT HOLDING: DEALS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 154
SEPTODONT HOLDING: EXPANSIONS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 155
DENTSPLY SIRONA: COMPANY OVERVIEW
 
 
 
 
TABLE 156
DENTSPLY SIRONA: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 157
DENTSPLY SIRONA: DEALS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 158
PIERREL: COMPANY OVERVIEW
 
 
 
 
TABLE 159
PIERREL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 160
PIERREL: PRODUCT LAUNCHES, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 161
PIERREL: DEALS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 162
HUONS GLOBAL: COMPANY OVERVIEW
 
 
 
 
TABLE 163
HUONS GLOBAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 164
HUONS GLOBAL: EXPANSIONS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 165
HUONS GLOBAL: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 166
NORMON: COMPANY OVERVIEW
 
 
 
 
TABLE 167
NORMON: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 168
DFL INDÚSTRIA E COMÉRCIO S/A: COMPANY OVERVIEW
 
 
 
 
TABLE 169
DFL INDÚSTRIA E COMÉRCIO S/A: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 170
ULTRADENT PRODUCTS INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 171
ULTRADENT PRODUCTS INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 172
ULTRADENT PRODUCTS INC.: DEALS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 173
ULTRADENT PRODUCTS INC.: EXPANSIONS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 174
ULTRADENT PRODUCTS INC.: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
 
 
 
 
TABLE 175
PRIMEX PHARMACEUTICALS: COMPANY OVERVIEW
 
 
 
 
TABLE 176
PRIMEX PHARMACEUTICALS: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 177
KEYSTONE INDUSTRIES: COMPANY OVERVIEW
 
 
 
 
TABLE 178
KEYSTONE INDUSTRIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 179
CLARBEN LABORATORIES: COMPANY OVERVIEW
 
 
 
 
TABLE 180
CLARBEN LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 181
HIKMA PHARMACEUTICALS PLC: COMPANY OVERVIEW
 
 
 
 
TABLE 182
HIKMA PHARMACEUTICALS PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 183
ZEYCO: COMPANY OVERVIEW
 
 
 
 
TABLE 184
ZEYCO: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 185
NEW STETIC S.A.: COMPANY OVERVIEW
 
 
 
 
TABLE 186
NEW STETIC S.A.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 187
CETYLITE, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 188
CETYLITE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 189
ICPA HEALTH PRODUCTS LIMITED: COMPANY OVERVIEW
 
 
 
 
TABLE 190
ICPA HEALTH PRODUCTS LIMITED: PRODUCTS/SERVICES/SOLUTIONS OFFERED
 
 
 
 
TABLE 191
CENTRIX, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 192
ZYMETH PHARMACEUTICAL: COMPANY OVERVIEW
 
 
 
 
TABLE 193
DMG AMERICA LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 194
GC SHOWAYAKUHIN CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 195
YOUNG INNOVATIONS, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 196
CROSSTEX INTERNATIONAL, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 197
MARK3 (CARGUS INTERNATIONAL, INC.): COMPANY OVERVIEW
 
 
 
 
TABLE 198
J. MORITA CORP.: COMPANY OVERVIEW
 
 
 
 
TABLE 199
KULZER GMBH: COMPANY OVERVIEW
 
 
 
 
TABLE 200
INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
DENTAL ANESTHETICS MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
 
 
 
 
FIGURE 7
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 
 
 
 
FIGURE 8
REVENUE SHARE ANALYSIS ILLUSTRATION: SEPTODONT HOLDING
 
 
 
 
FIGURE 9
SUPPLY-SIDE MARKET SIZE ESTIMATION: DENTAL ANESTHETICS MARKET (2024)
 
 
 
 
FIGURE 10
BOTTOM-UP APPROACH
 
 
 
 
FIGURE 11
TOP-DOWN APPROACH
 
 
 
 
FIGURE 12
CAGR PROJECTIONS FROM DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS (2025–2030)
 
 
 
 
FIGURE 13
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 14
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 15
DENTAL ANESTHETICS MARKET, BY DRUG TYPE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 16
DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 17
DENTAL ANESTHETICS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 18
GEOGRAPHIC SNAPSHOT OF DENTAL ANESTHETICS MARKET
 
 
 
 
FIGURE 19
RISING INCIDENCE OF DENTAL DISEASES TO DRIVE MARKET
 
 
 
 
FIGURE 20
INJECTABLE ANESTHETICS SEGMENT IN SOUTH KOREA LED ASIA PACIFIC MARKET IN 2024
 
 
 
 
FIGURE 21
INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
FIGURE 22
ASIA PACIFIC REGION TO DOMINATE MARKET DURING FORECAST PERIOD
 
 
 
 
FIGURE 23
EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
 
 
 
FIGURE 24
DENTAL ANESTHETICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 25
UK: PROJECTED NUMBER OF ADULTS (16 YEARS AND OLDER) WITH DENTAL CARIES, 2020–2050 (MILLION)
 
 
 
 
FIGURE 26
DENTAL ANESTHETICS MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 27
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL ANESTHETICS MARKET (JANUARY 2014–DECEMBER 2024)
 
 
 
 
FIGURE 28
TOP PATENT APPLICANT COUNTRIES FOR DENTAL ANESTHETICS (JANUARY 2014–DECEMBER 2024)
 
 
 
 
FIGURE 29
DENTAL ANESTHETICS MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 30
DENTAL ANESTHETICS MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 31
DENTAL ANESTHETICS MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
FIGURE 32
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN DENTAL ANESTHETICS MARKET
 
 
 
 
FIGURE 33
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF END USERS
 
 
 
 
FIGURE 34
KEY BUYING CRITERIA FOR END USERS
 
 
 
 
FIGURE 35
DENTAL ANESTHETICS MARKET: ADJACENT MARKET ANALYSIS
 
 
 
 
FIGURE 36
DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
 
 
 
 
FIGURE 37
EUROPE: DENTAL ANESTHETICS MARKET SNAPSHOT
 
 
 
 
FIGURE 38
NORTH AMERICA: DENTAL ANESTHETICS MARKET SNAPSHOT
 
 
 
 
FIGURE 39
ASIA PACIFIC: DENTAL ANESTHETICS MARKET SNAPSHOT
 
 
 
 
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS IN DENTAL ANESTHETICS MARKET (2024)
 
 
 
 
FIGURE 41
DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 42
DENTAL ANESTHETICS MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 43
DENTAL ANESTHETICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 44
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 45
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 46
DENTAL ANESTHETICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
 
 
 
 
FIGURE 47
DENTSPLY SIRONA: COMPANY SNAPSHOT
 
 
 
 
FIGURE 48
HUONS GLOBAL: COMPANY SNAPSHOT
 
 
 
 
FIGURE 49
HIKMA PHARMACEUTICALS PLC: COMPANY SNAPSHOT
 
 
 
 

Methodology

The study comprised four main activities aimed at estimating the current size of the dental anesthetics market. First, comprehensive secondary research was conducted to gather information on the market, as well as related and parent markets. Next, the findings, assumptions, and estimations were validated through primary research with industry experts across the value chain. Both top-down and bottom-up approaches were employed to determine the overall market size. Finally, market breakdown and data triangulation were utilized to estimate the sizes of segments and subsegments within the market.

Secondary Research

In the secondary research process, various sources were utilized to gather information on the dental anesthetics market. These sources included annual reports, press releases, and investor presentations from companies, as well as white papers, certified publications, and articles by recognized authors. We also referred to reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva. This research helped us identify key players in the market and allowed us to classify and segment the data according to industry trends, down to the most detailed level. Additionally, we compiled a database of key industry leaders using the information obtained from our secondary research.

Primary Research

Extensive primary research was conducted after gathering information on the dental anesthetics market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries. Data was collected through questionnaires, emails, and telephone interviews.

Primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), and Directors from business development, marketing, and product development/innovation teams. This also encompassed key executives from dental anesthetics manufacturers, distributors, and key opinion leaders.

A breakdown of the primary respondents for the dental anesthetics market is provided below:

Dental Anesthetics Market

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Others include sales, marketing, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 300 million, Tier 2 = USD 100 million to USD 300 million, and Tier 3 = < USD 100 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The research methodology used to estimate the size of the dental anesthetics market includes the following details:

The market sizing was undertaken from the global side.

Country-level Analysis: The size of the dental anesthetics market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall dental anesthetics market was obtained from secondary data and validated by primary participants to arrive at the total dental anesthetics market. Primary participants further validated the numbers.

Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:

  • Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
  • Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

At each point, the assumptions and approaches were validated by industry experts who were contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall dental anesthetics market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

Global Dental Anesthetics Market Size: Top-down and Bottom-up Approach

Dental Anesthetics Market

Data Triangulation

After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using both the top-down and bottom-up approaches.

Market Definition

Local dental anesthetics are medications that are injected directly into the area of the mouth where a dental procedure will be performed. They work by temporarily blocking nerve signals in that specific region, effectively numbing the site and preventing pain while the patient remains fully conscious. These anesthetics are primarily classified into two types based on their chemical structure: amides (such as lidocaine and articaine) and esters (such as benzocaine and procaine). They are mainly administered through two routes: injectable methods (infiltration or nerve block) and topical applications (gels, sprays, or ointments applied to the mucosa).

Stakeholders

  • Dental Anesthetics Manufacturers
  • Raw Material Suppliers for Dental Anesthetics
  • Suppliers and Distributors of Dental Anesthetics Products
  • Healthcare Service Providers
  • Teaching Hospitals and Academic Medical Centers
  • Government Bodies/Municipal Corporations
  • Regulatory Bodies
  • Medical Research Institutes
  • Business Research and Consulting Service Providers
  • Venture Capitalists
  • Market Research and Consulting Firms

Report Objectives

  • To describe, analyze, and forecast the dental anesthetics market by drug type, route of administration, end user, and region
  • To describe and forecast the dental anesthetics market for key regions, such as North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the dental anesthetics market
  • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile the key players and comprehensively analyze their market shares and core competencies in the dental anesthetics market
  • To analyze competitive developments such as partnerships, collaborations, acquisitions, product launches, expansions, and R&D activities in the dental anesthetics market
  • To benchmark players within the market using the proprietary Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business and product strategy

 

Key Questions Addressed by the Report

Which are the top industry players in the global dental anesthetics market?

Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Indústria e Comércio S/A (Brazil), Ultradent Products Inc. (US), Clarben Laboratories (Spain), New Stetic S.A (Colombia), and Primex Pharmaceuticals (Switzerland).

Which are the segments that have been included in this report?

By Drug Type, By Route of Administration, By End User, By Region

Which geographical region is dominating the dental anesthetics market?

Europe dominated the dental anesthetics market in 2024, followed by North America, Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries.

Which is the leading segment in the dental anesthetics market, by drug type?

The lidocaine segment accounted for the largest share of the dental anesthetics market by drug type.

What is the CAGR of the global dental anesthetics market?

The global dental anesthetics market is projected to grow at a CAGR of 4.0% from 2025 to 2030.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Dental Anesthetics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Dental Anesthetics Market

DMCA.com Protection Status